Source:http://linkedlifedata.com/resource/pubmed/id/16056025
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
437
|
pubmed:dateCreated |
2005-8-1
|
pubmed:abstractText |
Staphylococcus aureus and Staphylococcus epidermidis associated with implantable medical devices, are often difficult to treat with conventional antimicrobials. Formation of a biofilm and subsequent production of toxins are two distinct mechanisms considered important in foreign body infections. Staphylococcal virulence is caused by a complex regulatory process, which involves cell-to-cell communication through the release and response to chemical signals in a process known as quorum sensing. We explored the possibility of preventing infections by interfering with biofilm formation and toxin production using the quorum sensing inhibitor ribonucleic-acid-III-inhibiting peptide. In our studies ribonucleic-acid-III-inhibiting peptide prevented graft-associated infections caused by all species of staphylococci tested so far, including methicillin resistant S. aureus and S. epidermidis. Ribonucleic-acid-III-inhibiting peptide also enhances the effects of antibiotics and cationic peptides in the clearance of normally recalcitrant biofilm infections. Ribonucleic-acid-III-inhibiting peptide is nontoxic, highly stable, and no resistant strains have been found so far, suggesting that ribonucleic-acid-III-inhibiting peptide may be used to coat medical devices or used systemically to prevent infections. When the target of ribonucleic-acid-III activating protein activity is disrupted, biofilm formation is reduced under flow and static conditions and genes important for toxin production or biofilm formation are down-regulated. These in vitro data help explain why ribonucleic-acid-III-inhibiting peptide seems to be effective in preventing staphylococcal infections.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/MtrB protein, Bacteria,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNAIII inhibiting peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0009-921X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
48-54
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16056025-Animals,
pubmed-meshheading:16056025-Bacterial Proteins,
pubmed-meshheading:16056025-Biofilms,
pubmed-meshheading:16056025-Colony Count, Microbial,
pubmed-meshheading:16056025-Disease Models, Animal,
pubmed-meshheading:16056025-Injections, Intraperitoneal,
pubmed-meshheading:16056025-Male,
pubmed-meshheading:16056025-Oligopeptides,
pubmed-meshheading:16056025-Prosthesis-Related Infections,
pubmed-meshheading:16056025-RNA-Binding Proteins,
pubmed-meshheading:16056025-Rats,
pubmed-meshheading:16056025-Rats, Wistar,
pubmed-meshheading:16056025-Staphylococcal Infections,
pubmed-meshheading:16056025-Staphylococcus epidermidis,
pubmed-meshheading:16056025-Transcription Factors,
pubmed-meshheading:16056025-Treatment Outcome,
pubmed-meshheading:16056025-Virulence
|
pubmed:year |
2005
|
pubmed:articleTitle |
Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.
|
pubmed:affiliation |
Tufts University School of Veterinary Medicine, Department of Biomedical Sciences, North Grafton, MA 01536, USA. naomi.balaban@tufts,edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|